Transcatheter Pulmonary Valve Market By Product Type (Self-expanding Valves, Balloon-expandable Valves), By Technology (Catheter-based Technology, Mechanical Technology, Biological Technology, Hybrid Technology), By Application (Congenital Heart Diseases, Pulmonary Valve Replacement, Right Ventricular Outflow Tract (RVOT) Dysfunction, Other), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics Cardiac Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Self-expanding Valves
• Balloon-expandable Valves

By Technology Type

• Catheter-based Technology
• Mechanical Technology
• Biological Technology
• Hybrid Technology

By Application

• Congenital Heart Diseases
• Pulmonary Valve Replacement
• Right Ventricular Outflow Tract Dysfunction
• Other

By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics Cardiac Centers

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Medtronic plc
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Abbott Laboratories
• Artivion Inc.
• Braile Biomédica
• JenaValve Technology Inc.
• LivaNova PLC
• Venus Medtech (Hangzhou) Inc.
• Colibri Heart Valve LLC
• Labcor Laboratórios Ltda.
• Direct Flow Medical
• Bracco Group
• Transcatheter Technologies GmbH
• Meril Life Sciences Pvt. Ltd.